Literature DB >> 237470

Activity of pure streptovaricins and fractionated streptovaricin complex against Friend virus.

J S Horoszewicz, K L Rinehart, S S Leong, W A Carter.   

Abstract

Chromatographic fractionation of streptovaricin complex yields two stable components enriched (4- to 16-fold) in activity directed against the polycythemic strain of Friend virus; both components apparently contain no streptovaricins. When compared with their unfractionated parent streptovaricin complex, eight individual intact streptovaricins (A through G and J) show at least a 30-fold reduction in antiviral activity. These results further support the conclusion that the diversified biological properties of streptovaricin complex probably reside in different molecular structures.

Mesh:

Substances:

Year:  1975        PMID: 237470      PMCID: PMC429124          DOI: 10.1128/AAC.7.3.281

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  Streptovaricin. I. Discovery and biologic activity.

Authors:  P SIMINOFF; R M SMITH; W T SOKOLSKI; G M SAVAGE
Journal:  Am Rev Tuberc       Date:  1957-04

3.  Antivirion effects of streptovaricin complex against Friend virus.

Authors:  J S Horoszewicz; S S Leong; D M Byrd; W A Carter
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

4.  Selective inhibition by streptovaricin of splenomegaly induced Rauscher leukaemia by virus.

Authors:  E C Borden; W W Brockman; W A Carter
Journal:  Nat New Biol       Date:  1971-08

5.  Streptovaricins inhibit focus formation by MSV (MLV) complex.

Authors:  W A Carter; W W Brockman; E C Borden
Journal:  Nat New Biol       Date:  1971-08

6.  Streptovaricins inhibit RNA dependent DNA polymerase present in an oncogenic RNA virus.

Authors:  W W Brockman; W A Carter; L H Li; F Reusser; F R Nichol
Journal:  Nature       Date:  1971-03-26       Impact factor: 49.962

7.  Studies on antimicrobial substance B 44 P (streptovaricin) produced by a strain of actinomycetes. II. Microbiological and pharmacological studies.

Authors:  H Yamazaki
Journal:  J Antibiot (Tokyo)       Date:  1968-03       Impact factor: 2.649

8.  Relative biological activities of individual streptovaricins and streptovaricin acetates.

Authors:  K L Rinehart; F J Antosz; K Sasaki; P K Martin; M L Maheshwari; F Reusser; L H Li; D Moran; P F Wiley
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

9.  Inhibition of Poxvirus replication by streptovaricin.

Authors:  N A Quintrell; B R McAuslan
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

10.  RNA-directed DNA polymerase and virus-induced leukemia in mice.

Authors:  A M Wu; R C Ting; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

View more
  1 in total

1.  Differential susceptibility of spleen focus-forming virus and murine leukemia viruses to ansamycin antibiotics.

Authors:  J S Horoszewicz; S S Leong; W A Carter
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.